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 Introduction 
 In the context of tissue engineering and regenerative medicine 
(TERM), bioprinting technologies emerged as an enabling 
tool for creating three-dimensional (3D) functional tissue con-
structs with tailored biological and mechanical properties (see 
the Introduction article in this issue).  1 , 2  Bioprinting has been 
defi ned as “the use of computer-aided transfer processes 
for patterning and assembling living and non-living materials 
with a prescribed two-dimensional or 3D organization in order 
to produce bioengineered structures serving in TERM, phar-
macokinetic, and basic cell-biology studies.”  3  Together with 
bioassembly, bioprinting is one of the two main approaches of 
biofabrication in TERM.  4 
 Different technologies have been proposed for patterning, 
depositing, and 3D shaping bioinks, which can be grouped 
into (micro)extrusion,  5  inkjet,  6  and photopolymerization.  7  The 
simultaneous printing of biomaterials and cells allowed the 
achievement of several milestones, such as increased seeding 
effi ciency and avoidance of nonhomogeneous cell distribution 
due to postfabrication seeding.  8  Extrusion-based technologies 
are currently targeted as promising for building clinically 
relevant constructs.  9  Although they have limited resolution, 
several companies are investing in this growing market,  10 
mainly proposing extrusion-based bioprinters with related 
bioinks.  11 
 However, recapitulating  in vitro the 3D multiscale micro-
architecture with multiple cell types as well as the extracellular 
matrix (ECM) physicochemical cues of living tissues have 
remained unsolved challenges.  12  The diffusion of nutrients 
and waste products above a distance of 150–200  μ m is no 
longer effi cient, compromising cellular viability and function 
in a short time.  13  Growth factors are specifi cally located in 
the ECM to guide tissue development,  14  and different types 
of cells are in close contact and in continuous cross-talking.  15 
Bioprinting a single cell type together with a single biomaterial 
cannot, therefore, bring further advancement. 
 This article describes recent advances in controlling spatial 
heterogeneity of chemical and physical properties of scaffolds 
using bioprinting technologies. We also discuss how such bio-
printed artifi cial tissues have a prescribed cellular composition 
and spatial arrangement. As different bioprinting technologies 
have been reviewed elsewhere,  9 – 11 , 16  we focus on the advan-
tages and constraints for multimaterial processing, by analyz-
ing attempts to merge different bioprinting technologies. 
 General considerations for multicellular and 
multimaterial bioprinting 
 Regardless of the chosen technology and the well-established 
issues regarding pores (i.e., pore size and shape, intercon-
nectivity, and total porosity) and mechanical properties that 
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each scaffold must present, common considerations can be 
highlighted.
Bioprinting technologies usually follow a layer-by-layer 
approach, where each layer is built and stacked over the 
previous one until completion of the 3D structure. Bottom 
layers have to provide mechanical support and sustain the 
weight of the upper layers without collapsing. The overhang-
ing components need to resist without large, gravity-induced 
deformations.
The fabrication of a layer can be described as transfer of 
energy (mechanical, thermal, chemical, and electromagnetic) 
from the bioprinting machine to the cell-laden material. 
This process can affect cell phenotype and viability (e.g., by 
interacting with DNA), damaging cell membranes or altering 
osmotic equilibrium between cells and the external environ-
ment. Furthermore, sterility has to be assured in each step 
of the bioprinting procedure, by an accurate control of the 
material reservoirs and of the building chamber.
Nanotopography plays a fundamental role in cell adhesion.17 
Many studies demonstrate this feature as an intrinsic aver-
age property of the bioprinted material. However, bioprinting 
technologies should achieve submicrometer resolution to offer 
greater control over the entire bioprinted construct. Although 
millimetric biological constructs can be sufficient for in vitro 
organs (i.e., reverse-engineered “mature” functional tissues, 
comprising fundamental elements, architectures, and physical/
chemical stimuli), macroscale constructs will be necessary for 
clinical applications. Maintaining a submicrometer resolution 
for long distances (>3 cm) can increase the cost by a factor of 
10 (e.g., 10 μm to 1 μm accuracy).
Hydrogels are considered the elected materials for bio-
fabrication due to their similarities with the ECM.9 Several 
hydrogels have been processed. However, further advances 
in biomaterials are required to enable printing low-viscosity 
materials with improved biological properties that will enhance 
the resulting tissue function.18 Extrusion-based and inkjet 
technologies require low viscosity bioinks, which allow 
the use of a thinner nozzle and an increase in the dispensing 
speed. These factors will result in higher printing resolutions, 
shorter fabrication time, and reduced (shear) stress on cells.19 
This rheological behavior should be coupled with a fast 
gelation process to retain the shape impressed by the printing 
procedure.9 Control over the gel stiffness and swelling is nec-
essary for structural support to provide the proper mechani-
cal cues to cells.20 These cell-responsive bioinks allow for 
control of the spreading and migration of cells.18 The use of a 
dense polymer matrix (generally with a concentration higher 
than 5 wt%), necessary to have the right viscosity for printing 
definition,21 can prevent spreading, migration, and prolifera-
tion. Therefore, these hydrogels are not ideal candidates for 
cell-laden constructs.22
From a rheological point of view, even if bioinks form a 
solid structure, they are normally described just by indicating 
the viscosity before the gel point.23 For hydrogels, gelation 
time and storage modulus have to be determined by oscillatory 
time sweep and frequency sweep.19,24 These analyses will con-
firm the viscoelasticity of the gel and will determine if there 
is a specified time frame for printing.11,19 Gelation is necessary 
for the stabilization of the intralayer and interlayer structures 
and is generally achieved by physical, thermal,25 ionical,26 or 
chemical and photochemical means.27–29 Several studies have 
explored the combination of a first, rapid, physical stabilization 
followed by a second stronger chemical bond.14,29
Rutz and co-workers customized several bioink formu-
lations in terms of composition, degree of cross-linking, and 
polymer concentration, by exploiting the functionality of light 
cross-linking with long length chemical cross-linkers, based 
on poly(ethylene glycol).19 The Khademhosseini group, 
instead, combined the initial structural integrity given by ionic 
cross-linking alginate fibers with the UV photopolymerization 
of cell-laden gelatine-methacryloyl coaxially extruded (see 
the next section).30
A final consideration of the so-called “scaffold-free bioprint-
ing” can be outlined. This process, pioneered by Forgacs and 
co-workers, foresees the use of tissue spheroids, an aggregate 
of a large number (approximately 107 cells/ml)31 of hetero-
geneous cells that will be remodeled after bioprinting. Such 
spheroids are important for recapitulating the minimal func-
tions of a targeted tissue or organ. Spheroid remodeling is due 
to the tissue liquidity driving force32 sustained by temporarily 
inserting a support matrix usually made of agarose. The scaling 
up of these tissue constructs implies that a large number of 
cells must be extracted from the patient and expanded in vitro, 
which will result in cell senescence (i.e., cells becoming older), 
and consequently, may impinge on their functionality.33
Multinozzle and microfluidic approaches for 
extrusion-based bioprinting
Extrusion-based bioprinting is characterized by a robotic 
micropositioner, which describes trajectories in 3D space, 
whereas hydrogel bioinks are extruded in cylindrical filaments 
by a fluid-dispensing system. Comprehensive reviews of fluid 
dispensing systems are available, and can be grouped into 
pneumatic (with or without a valve) or mechanical (piston or 
screw-driven).5,10 Recently, even lab pipettes have been used 
as extruders, although the system, as indicated by the authors, 
was completely manual.33
Generally, volumetric pumps offer higher control over fluid 
dispensing and do not need continuous calibration of the sys-
tem if the bioink viscosity changes.11 Because of the large 
driving forces that can be generated, very viscous solutions can 
be printed, and screw-driven extruders can dispense molten 
polymers, such as poly(ε-caprolactone) (PCL).
Extrusion-based bioprinters are extremely flexible, allow-
ing the use of heterogeneous bioinks, both in terms of bioma-
terial and cell type composition, even if the bioprinters present 
a single extruder. Cell-laden hydrogels containing multiple 
cell types and high-cell-density tissue spheroids (which are 
intrinsically heterogeneous) have been successfully printed.32,34,35 
Due to the high driving force available for extrusion, it was 
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possible to load hydrogel-based bioinks (1) with porous 
microspheres where cells can adhere and proliferate before 
printing, while hydrogels offer lubrication and glue after gela-
tion;33 and (2) with 3D printed microstructures, such as the 
so-called lockyballs, two-photon polymerized cages that trap 
tissue spheroids and guide their spatial organization.36
An extrusion-based bioprinter was successfully used to print 
decellularized ECM, which offers fibrous proteins, glycos-
aminoglycans (GAGs), and remnant growth factors mimick-
ing the native tissue microenvironment, thereby enabling cells 
to preserve their original functionalities. The final structure 
needs to be cross-linked after printing to avoid dissolution in 
aqueous environment after physical (thermal) gelation. The 
use of vitamin B2-induced UVA radiation cross-linking was 
demonstrated to reinforce the structure and to be cell-friendly 
toward cardiac progenitor cells.14
Self-assembling hydrogels, whose properties are driven by 
noncovalent interaction of their moieties,37 have been recently 
investigated due to their shear thinning behavior, which 
allows easy extrusion. These materials are used as substrate/
support materials in the so-called gel-in-gel printing because 
of their self-healing properties.38
Multimaterial and multicellular 3D scaffolds can also be 
fabricated by upscaling the complexity of the extrusion-based 
system. A first choice is the swapping of dispensing systems, 
which allows fabricating heterogeneous materials, such as the 
extrusion of PCL and alginate.39,40 This was also explored 
by building a bioprinter with multiple arms with independent 
motion paths and independent extruders.41
The multiplication of print heads introduces the problem 
of alignment of multiple nozzles. Alternatives include coaxial 
extrusion, mainly used for dispensing noncross-linked gel and 
the cross-linking solution (ionic + covalent cross-linking),30 or 
printers with a single print head and independent syringe pumps, 
utilizing a single nozzle and a selector valve.42 Another solution 
is the use of a single print head and a microfluidic system that 
mixes the various bioinks, coming from different reservoirs, 
before extruding a single multimaterial filament, characterized 
by a stable concentration gradient of the mixed bioinks across 
the filament section.43,44 Microfluidic techniques assemble mul-
tiple material inlets in a single outlet channel without mixing, 
due to low inertial forces in microscale cross-sectional channels. 
Even if the microfluidic approach is limited by the mixing of the 
same fluid solution with different solutes (or different concentra-
tions of the same solute), sub-needle (filament) resolution can 
be achieved. Currently proposed devices yield graded outlets 
by modulating the inlets velocities, but greater variety can be 
obtained by adding more complex microfluidic circuits.45
The main limitation in extrusion-based bioprinting is re-
lated to shear stresses in the flowing solution, which induce 
deformation in the cell membrane, affecting viability and 
phenotype stability during postprinting. Nair et al.46 have dis-
cussed the effects of shear stress (see also Table I).
Extrusion-based bioprinters have been successfully used 
to indirectly create thick vascularized tissues (up to 1 cm in 
thickness) by 3D printing a fugitive vascular template on 
which a cell-laden matrix is cast, avoiding shear stress on 
cells. In an approach proposed by Miller,47 a sacrificial carbo-
hydrate glass was printed at elevated temperature (>100°C), 
protectively coated, and then removed before introducing 
a homogeneous cell-laden matrix. Lewis et al.48 instead pro-
posed a more complex procedure that consisted of (1) a fugi-
tive ink composed of pluronic (poloxamer or copolymers) and 
thrombin; (2) a cell-laden ink (deposited through extrusion) 
that contains gelatin, fibrinogen, and human mesenchymal 
stromal cells; and (3) a castable ECM material that contains gela-
tin, fibrinogen, human neonatal dermal fibroblasts, thrombin, 
and transglutaminase (TG). This matrix is cast over the printed 
inks. After casting, thrombin induces fibrinogen cleavage and 
rapid polymerization into fibrin in both the cast matrix, and 
through diffusion, in the printed cell ink. Similarly, TG dif-
fuses from the molten casting matrix and slowly cross-links 
the gelatin and fibrin. The fugitive ink is dissolved by cooling, 
forming a perfusable vascular network, which is endothelial-
ized with human umbilical vein endothelial cells and perfused 
via an external pump (Figure 1). Interestingly, this complex 
tissue construct was observed over several weeks (>6 weeks), 
allowing a relatively long-term study of emergent biological 
phenomena in a complex microenvironment.48
Inkjet-based bioprinting
Inkjet-based bioprinters allow noncontact delivery of small 
droplets of bioinks at controlled positions on a substrate. 
Piezoelectric and thermal are the two most common mecha-
nisms for drop-on-demand (DOD) formation. The piezoelectric 
inkjet printer uses piezoelectric crystals to produce acoustic 
waves to force the liquid through the nozzle. The thermal 
inkjet system produces pulses of pressure by vaporizing the 
bioink around the heating element, expelling the droplets 
out from the print head.6 Heterogeneous patterns of structural 
proteins,49 enzymes,50 antibodies,51 DNA/RNA,52 and living 
cells53 have been successfully printed, demonstrating the 
inherent multimaterial nature of this technology. However, 
intrinsic limitations and issues should be highlighted, such 
as those involving the printability of inks, described by 
the Ohnesorge number (Oh). This dimensionless number 
expresses the ratio of the viscous force to the surface tension 
during drop formation, and thus depends on the surface ten-
sion, density, viscosity, and nozzle size.54 High viscous forces 
(Oh > 1) dissipate the energy for expelling the drop, while 
Table I. Influence of shear stress on cell viability during extrusion-
based 3D printing, using a pneumatic system with a microvalve.46
Maximum Shear Stress (kPa) Viability (%)
10 90
30 80
50 70
130 60
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high surface tension forces (Oh < 0.1) lead to many satellite 
droplets, limiting the printing quality. For biological fluids, 
the surface tension upper limit is that of pure water, because 
the density of electrolytes and buffers does not deviate more 
than a few percent from that of water. Hence, the only physi-
cal parameter in Oh that shows significant variation between 
biological fluids is the viscosity. Considering a typical nozzle 
diameter of 20–100 µm, a fluid viscosity of approximately 
30 mPa × s is a practical upper limit for printability.6
Even if the drop generation rate was increased up to 30 kHz, 
the bioprinting of clinically relevant constructs would be 
difficult to achieve,9 due to the small volume of each droplet. 
Currently, commercially available DOD printers are char-
acterized by a drop volume of 1–100 pl, easily subjected to 
evaporation problems and related “coffee ring” effects.
Bioink damage has been indicated as the main weakness 
of inkjet-based bioprinters. Several studies have shown that 
biological materials (including cells) are not affected by the 
local high temperatures (300°C) of the heating element in the 
thermal DOD process, due to the short period of exposure 
(2 μs).54 The main concern about piezoelectric printing is pos-
sible sonication due to the frequency (8–20 kHz) used during 
printing,6 although parametric studies on piezo-waveform 
parameters revealed a viability higher than 
95%.55 However, both thermal and piezo print-
ers can induce temporary damage in cell mem-
branes by shear stresses, due to the passage 
of the bioink through narrow nozzles.6 Finally, 
cell viability can be influenced by the drop 
impact on the target substrate, where the drop 
velocity can range from 1–10 m/s. In this case, 
the stiffness of the substrate is fundamental 
to absorb the excess energy and dampen the 
impact, thereby protecting the cells.56
Despite these limitations, complex 3D struc-
tures have been created53,57 by printing cells and 
a gelation agent onto a prepolymer substrate, 
such as calcium ions onto alginate58 or calcium 
ions and thrombin over fibrinogen.59 Orsi et al. 
demonstrated inkjet printing of a hydrogel and 
cross-linker contained in the same solution by 
printing gelatin and (3-glycidyloxypropyl) tri-
methoxysilane, a cross-linker that reacts once 
the solvent evaporates. Because of the versatil-
ity of inkjet printing, the researchers were also 
able to include pH-sensitive nanoparticles in 
the printing solution, creating a scaffold with 
in situ or built-in sensors.60
Three-dimensional inkjet bioprinting of pho-
topolymerizable gels is a well-defined approach 
that is currently under investigation. In particu-
lar, thermoreversible gelation can be useful for 
the initial fabrication of a scaffold, followed 
by a photopolymerization reaction to maintain 
the scaffold structure.61 Cui et al., who printed 
chondrocytes (cartilage cells) directly into an explanted (ex 
vivo) articular cartilage defect, reported that being a noncon-
tact technology, inkjet printing is well suited for decorating 
scaffolds fabricated with other technologies62 or directly print-
ing in situ.63
Hybrid technologies
Electrospinning is the most versatile technique to produce 
nanofibers, as it allows large-scale production, combining differ-
ent materials at the same time.64 The classical setup of an elec-
trospinning system consists of a high voltage supply, a syringe 
with a metal needle of small diameter, and a metal collecting 
screen (collector). The presence of a high voltage between the 
needle and the collector allows the development of an elec-
trically charged jet of polymer solution (or melted polymer) 
out from the needle. Before reaching the collector, the solvent 
evaporates from the solution, and the polymer solidifies as 
nanofibers, which impact the collector and develop a web 
of small fibers. The topology of the final structure can be 
modified by tuning the feed solution (solvent, concentration, 
viscosity, and molecular weight), processing conditions (electric 
field, distance, and shape of the collector), and environmental 
parameters (temperature and humidity).64
Figure 1. Example of multicellular and vascularized scaffold, fabricated by combining a 
fugitive ink, a cell-laden ink, and a casting of a biomatrix. (a) Fabrication steps (i) Three-
dimensional bioprinting of fugitive ink and cell-laden ink, (ii) casting of extracellular matrix 
material, (iii) removal of fugitive ink for creating the vascular network channels, and (iv) seeding 
of endothelial cells and perfusion of the vascular network. (b) Fabricated construct (fugitive 
[red] and cell-laden inks [green]; scale bar = 5 mm) and (c) confocal microscope image 
through a cross section of 1-cm-thick vascularized bone tissue construct after 30 days 
of active perfusion and in situ differentiation. Red: RFP-HUVECs, primary red fluorescent 
protein-expressing human umbilical vein endothelial cells; green, actin; violet, osteocalcin; 
blue, DAPI, 4′,6-diamidino-2-phenylindole. Scale bar = 1.5 mm. Adapted with permission 
from Reference 48. © 2016 National Academy of Sciences.
https://www.cambridge.org/core/terms. https://doi.org/10.1557/mrs.2017.165
Downloaded from https://www.cambridge.org/core. Universiteit Maastricht, on 09 Oct 2020 at 11:13:09, subject to the Cambridge Core terms of use, available at
MultiMaterial, heterogeneous, and Multicellular three-diMensional bioprinting
582 MRS BULLETIN • VOLUME 42 • AUGUST 2017 • www.mrs.org/bulletin 
Combinations of extrusion-based bioprinting technologies 
and electrospinning have been investigated. Moroni et al.65,66 
integrated 3D fiber deposition (extrusion-based additive manu-
facturing of molten material) with electrospinning techniques to 
fabricate a new set of multiscale scaffolds for cartilage regen-
eration. They fabricated poly(ethylene oxide terephthalate)/
poly(butylene terephthalate) scaffolds that were characterized 
by periodic alternation between an additive manufactured 
structure, to obtain an architecture with appropriate mechani-
cal properties, and electrospun fibers, to provide additional 
surface area and improve the cell-adhesion phenomena.
Park et al.67 followed a similar process, using PCL both for 
the additive manufactured structure and the electrospun mesh. 
Criscenti et al. fabricated a triphasic scaffold for the regenera-
tion of the bone–ligament interface by combining a 3D fiber-
deposited PCL structure and a poly(lactic-co-glycolic acid) 
electrospun mesh (Figure 2). This scaffold presented a gradient 
of physical and mechanical properties, which elicited different 
biological responses from human mesenchymal stromal cells.68
Multiscale structures combining synthetic and natural 
polymers have been demonstrated by the Vozzi group, where a 
PCL additive manufactured structure was functionalized with a 
gelatin spun mesh. The nanotexture produced by electrospinning 
enhanced the revascularization of ischemic tissues (i.e., tissues 
with a restriction in the blood supply, causing a local shortage of 
oxygen and nutrients) in a mouse model.69 The combination of 
melt electrospinning (i.e., the electrospinning of a molten poly-
mer) with a three-axis micropositioner and the layer-by-layer 
deposition approach led to “melt electrohydrodynamic 3D print-
ing.” PCL filaments of approximately 10 μm in diameter were 
precisely stacked into 3D straight walls with fine surface qual-
ity.70 A hybrid inkjet printing/electrospinning system was used to 
fabricate viable tissues for cartilage tissue-engineering applica-
tions. PCL spun fibers alternated with inkjet-printed chondro-
cytes suspended in a fibrin–collagen hydrogel were fabricated up 
to a tissue construct thickness of 1 mm. The fabricated constructs 
formed cartilage-like tissues both in vitro and in vivo, as evi-
denced by the deposition of Type II collagen and GAGs.62
Future trends
Fabrication of functional tissue is a complex process, com-
prising a hierarchical arrangement of multiple cell types, 
including a multiscale network of vascular, neural, and lym-
phatic networks. Bioprinting technologies offer the opportu-
nity of hierarchical arrangement of cells and biomaterials in a 
3D microenvironment. Hybrid processes, multiple materials, 
and heterogeneous cell types are necessary to recapitulate 
the geometry, complexity, and longevity of human tissues. 
This article gave an overview of current approaches for 
selecting the best features of the various bioprinting approaches 
available today. Technology development is helping in accu-
racy and reproducibility of 3D structures with micrometric 
features, but the bioink is the fundamental component of this 
framework—it provides the biochemical and physical cues 
for cells and its rheological properties, and its stability after 
printing determines the working windows for processability. 
A variety of synthetic and natural bioinks have been proposed, 
which are expected to drive the market.
The ambition to mimic the highly dynamic and constantly 
changing morphologies of native tissues in response to sur-
rounding stimulants is pushing biofabrication research toward 
the so-called four-dimensional bioprinting, which is able to 
produce structures with the embedded ability of shape trans-
formation in time. In this strategy, stimuli-responsive bio-
materials are processed with 3D bioprinting technology to 
fabricate biologically active constructs that can alter shapes 
upon desired stimulation to achieve prescribed functionality.71 
Mathematical modeling for predicting these structural evolu-
tions, and the related cellular response, will be an invaluable 
tool for a deeper understanding of phenomena and conse-
quently the development of a better design of bioconstructs.
Advancements in bioprinting also can come from devel-
opments in other fields of 3D printing (e.g., the continuous 
liquid interface production technology),72 a stereolithography-
derived approach, which allows an extreme reduction in the 
printing time of a 3D object. This technological innovation 
relies on the introduction of an oxygen-containing “dead zone” 
between the solid part and the liquid precursor where solidi-
fication cannot occur, thanks to an oxygen-permeable optical 
window. The precursor liquid is then renewed by the upward 
movement of the growing solid part, instead of by the movement 
of the machine, thus reducing the printing time. If applied to 
bioprinting, we could reduce the time the cells spend in the 
bioprinter and thus limit their possible suffering.
Once fabricated, the post-bioprinting matu-
ration phase is as important as the bioprinting 
process itself. Bioreactors’ technologies can 
induce a more rapid maturation of tissues, 
multiscale vascularization, innervation, and 
lymphogenesis for survivability of tissues, and 
mechanical integrity. Multimaterial process-
ing has already demonstrated the potential 
to completely fabricate not only 3D cell-laden 
constructs, but also the complete framework, 
which can support tissue perfusion and is 
essential for a 3D model of in vitro tissue or 
organ maturation.
Figure 2. Example of multiscale and multimaterial scaffold fabricated using hybrid 
technologies. The 3DF region was built by extruding poly(ε-caprolactone) strands, while 
PLGA was electrospun on a specific location to fabricate a triphasic scaffold. (a) 3DF 
region (scale bar = 500 μm); (b) mixed region with electrospun PLGA over 3DF strands 
(scale bar = 200 μm); and (c) ESP region (scale bar = 20 μm).68 Note: 3DF, three-
dimensional fiber deposition; ESP, electrospinning; PLGA, poly(lactic-co-glycolic acid).
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